Management of chronic wounds in patients with pemphigus

References

• Bystryn J-C, Rudolph JL. Pemphigus. Lancet. 2005;366(9479):61–73. doi:10.1016/S0140-6736(05)66829-8
   PubMed Web of Science ®Google Scholar
• Kasperkiewicz M, Ellebrecht CT, Takahashi H, et al. Pemphigus. Nat Rev Dis Primers. 2017;3:17026. doi:10.1038/nrdp.2017.26
   PubMed Web of Science ®Google Scholar
• Bolognia J, Jorizzo JL, Schaffer JV. Dermatology. 3rd ed. [Philadelphia]; London: Elsevier Saunders; 2012.
   Google Scholar
• Joly P, Litrowski N. Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis). Clin Dermatol. 2011;29(4):432–436. doi:10.1016/j.clindermatol.2011.01.013
   PubMed Web of Science ®Google Scholar
• Brenner S, Wohl Y. A survey of sex differences in 249 pemphigus patients and possible explanations. SKINmed. 2007;6(4):163–165. doi:10.1111/skm.2007.6.issue-4
   Google Scholar
• Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K. Fitzpatrick’s dermatology in general medicine. In: McGraw-Hill’s Access Medicine Clinical Library. 8th ed. New York: McGraw-Hill; 2012. Available from: http://www.accessmedicine.com/resourceTOC.aspx?resourceID=505. Subscription required. Accessed July 22, 2019.
   Google Scholar
• Harman K, Brown D, Exton L, et al. British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris 2017. Br J Dermatol. 2017;177(5):1170–1201. doi:10.1111/bjd.15930
   PubMed Web of Science ®Google Scholar
• Reis VM, Toledo RP, Lopez A, Diaz LA, Martins JE; Research CGoFS. UVB-induced acantholysis in endemic Pemphigus foliaceus (Fogo selvagem) and Pemphigus vulgaris. J Am Acad Dermatol. 2000;42(4):571–576.
   PubMed Web of Science ®Google Scholar
• James KA, Culton DA, Diaz LA. Diagnosis and clinical features of pemphigus foliaceus. Dermatol Clin. 2011;29(3):405–412. doi:10.1016/j.det.2011.03.012
   PubMed Web of Science ®Google Scholar
• Dabiri G, Damstetter E, Phillips T. Choosing a wound dressing based on common wound characteristics. Adv Wound Care. 2016;5(1):32–41. doi:10.1089/wound.2014.0586
   Web of Science ®Google Scholar
• Hertl M. Pathogenesis, Clinical Manifestations, and Diagnosis of Pemphigus. UpToDate, Post TW (Ed), UpToDate. Waltham (MA): UpToDate Inc. Available from: https://www.uptodate.com. Accessed July 22, 2019.
   Google Scholar
• Bystryn J-C, Steinman NM. The adjuvant therapy of pemphigus: an update. Arch Dermatol. 1996;132(2):203–212.
   PubMedGoogle Scholar
• Murrell DF, Peña S, Joly P, et al. Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts. J Am Acad Dermatol. 2018. doi:10.1016/j.jaad.2018.02.021
   PubMed Web of Science ®Google Scholar
• Ahmed AR, Spigelman Z, Cavacini LA, Posner MR. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. N Engl J Med. 2006;355(17):1772–1779. doi:10.1056/NEJMoa062930
   PubMed Web of Science ®Google Scholar
• Gregoriou S, Efthymiou O, Stefanaki C, Rigopoulos D. Management of pemphigus vulgaris: challenges and solutions. Clin Cosmet Investig Dermatol. 2015;8:521. doi:10.2147/CCID
   PubMed Web of Science ®Google Scholar
• Joly P, Maho-Vaillant M, Prost-Squarcioni C, et al. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial. Lancet. 2017;389(10083):2031–2040. doi:10.1016/S0140-6736(17)30070-3
   PubMed Web of Science ®Google Scholar
• Kridin K. Emerging treatment options for the management of pemphigus vulgaris. Ther Clin Risk Manag. 2018;14:757. doi:10.2147/TCRM.S142471
   PubMed Web of Science ®Google Scholar
• Lapidoth M, David M, Ben-Amitai D, Katzenelson V, Lustig S, Sandbank M. The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study. J Am Acad Dermatol. 1994;30(5):752–757. doi:10.1016/s0190-9622(08)81506-x
   Web of Science ®Google Scholar
• Ratnam K, Phay K, Tan C. Pemphigus therapy with oral prednisolone regimens a 5-year study. Int J Dermatol. 1990;29(5):363–367.
   PubMed Web of Science ®Google Scholar
• Lever WF, White H. Treatment of pemphigus with corticosteroids: results obtained in 46 patients over a period of 11 years. Arch Dermatol. 1963;87(1):12–26. doi:10.1001/archderm.1963.01590130018006
   Google Scholar
• Harman K, Albert S, Black M. Guidelines for the management of pemphigus vulgaris. Br J Dermatol. 2003;149(5):926–937. doi:10.1111/j.1365-2133.2003.05665.x
   Web of Science ®Google Scholar
• Knudson RM, Kalaaji AN, Bruce AJ. The management of mucous membrane pemphigoid and pemphigus. Dermatol Ther. 2010;23(3):268–280. doi:10.1111/j.1529-8019.2010.01323.x
   Web of Science ®Google Scholar
• Mahmoudi H, Balighi K, Tavakolpour S, Daneshpazhooh M, Chams-Davatchi C. Trichloroacetic acid as a treatment for persistent oral mucosal lesions in pemphigus vulgaris. J Am Acad Dermatol. 2019;80(3):e51–e52. doi:10.1016/j.jaad.2018.08.039
   Web of Science ®Google Scholar
• Hsu D, Brieva J, Sinha A, Langan S, Silverberg JI. Comorbidities and inpatient mortality for pemphigus in the USA. Br J Dermatol. 2016;174(6):1290–1298. doi:10.1111/bjd.14463
   Web of Science ®Google Scholar
• Falanga V. Occlusive wound dressings: why, when, which? Arch Dermatol. 1988;124(6):872–877.
   Google Scholar
• Han S-K. Interactive wound dressings. In: Innovations and Advances in Wound Healing. Berlin: Springer; 2016:39–61.
   Google Scholar
• Armstrong DG. Basic Principles of Wound Management. UpToDate, Post TW (Ed), UpToDate. Waltham (MA): UpToDate Inc. 2019. Available from:. https://www.uptodate.com. Accessed July 22, 2019.
   Google Scholar
• Powers JG, Morton LM, Phillips TJ. Dressings for chronic wounds. Dermatol Ther. 2013;26(3):197–206. doi:10.1111/dth.12055
   Web of Science ®Google Scholar
• Broussard KC, Powers JG. Wound dressings: selecting the most appropriate type. Am J Clin Dermatol. 2013;14(6):449–459. doi:10.1007/s40257-013-0046-4
   PubMed Web of Science ®Google Scholar
• Borda LJ, Macquhae FE, Kirsner RS. Wound dressings: a comprehensive review. Curr Dermatol Rep. 2016;5(4):287–297. doi:10.1007/s13671-016-0162-5
   Google Scholar
• de la Feld SF, Sami N. . Local treatments and supportive care. In: Sami N, editor. Autoimmune Bullous Diseases: approach and management. Berlin: Springer; 2016:243–262.
   Google Scholar
• Blackman JD, Senseng D, Quinn L, Mazzone T. Clinical evaluation of a semipermeable polymeric membrane dressing for the treatment of chronic diabetic foot ulcers. Diabetes Care. 1994;17(4):322–325. doi:10.2337/diacare.17.4.322
   Web of Science ®Google Scholar
• Kim YJ, Lee SW, Hong SH, Lee HK, Kim EK. The effects of PolyMem (R) on the wound healing. J Korean Soc Plast Reconstr Surg. 1999;26(6):1165–1172.
   Google Scholar
• Benskin LL. PolyMem® Wic® Silver® Rope: a multifunctional dressing for decreasing pain, swelling, and inflammation. Adv Wound Care. 2012;1(1):44–47. doi:10.1089/wound.2011.0285
   Google Scholar
• Lehman JS, Murrell DF, Camilleri MJ, Kalaaji AN. Infection and infection prevention in patients treated with immunosuppressive medications for autoimmune bullous disorders. Dermatol Clin. 2011;29(4):591–598. doi:10.1016/j.det.2011.06.021
   Web of Science ®Google Scholar
• Ahmed AR, Moy R. Death in pemphigus. J Am Acad Dermatol. 1982;7(2):221–228. doi:10.1016/s0190-9622(82)70111-2
   Web of Science ®Google Scholar
• Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11:S1–S28.
   Web of Science ®Google Scholar
• Robson MC. Wound infection: a failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am. 1997;77(3):637–650.
   PubMed Web of Science ®Google Scholar
• Bowler P, Duerden B, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev. 2001;14(2):244–269. doi:10.1128/CMR.14.2.244-269.2001
   PubMed Web of Science ®Google Scholar
• Krasner D, Kane D. Chronic Wound Care: A Clinical Source Book for Healthcare Professionals. Wayne (PA): Health Management Publications; 1997.
   Google Scholar
• Lundberg CV, Frimodt-Møller N. Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model. Int J Antimicrob Agents. 2013;42(3):272–275. doi:10.1016/j.ijantimicag.2013.05.008
   PubMed Web of Science ®Google Scholar
• O’Donnell JA, Gelone SP, Safdar A, editors. Topical antibacterials. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Elsevier; 2015:452–462.e452.
   Google Scholar
• Lipsky BA, Hoey C. Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis. 2009;49(10):1541–1549. doi:10.1086/644732
   PubMed Web of Science ®Google Scholar
• O’Meara S, Richardson R, Lipsky BA. Topical and systemic antimicrobial therapy for venous leg ulcers. JAMA. 2014;311(24):2534–2535. doi:10.1001/jama.2014.4574
   PubMed Web of Science ®Google Scholar
• Leaper D. Appropriate use of silver dressings in wounds: international consensus document. Int Wound J. 2012;9(5):461–464. doi:10.1111/j.1742-481X.2012.01091.x
   PubMed Web of Science ®Google Scholar
• Fonder MA, Lazarus GS, Cowan DA, Aronson-Cook B, Kohli AR, Mamelak AJ. Treating the chronic wound: A practical approach to the care of nonhealing wounds and wound care dressings. J Am Acad Dermatol. 2008;58(2):185–206. doi:10.1016/j.jaad.2007.08.048
   PubMed Web of Science ®Google Scholar
• Lansdown AB. Silver. I: its antibacterial properties and mechanism of action. J Wound Care. 2002;11(4):125–130. doi:10.12968/jowc.2002.11.4.26389
   Google Scholar
• Wu CS, Hsu HY, Hu SCS, Chiu HH, Chen GS. Silver‐containing Hydrofiber Dressing is an Effective Adjunct in the Treatment of Pemphigus Vulgaris. Kaohsiung J Med Sci. 2009;25(11):622–627. doi:10.1016/S1607-551X(09)70567-4
   Web of Science ®Google Scholar
• Masjedi H, Malekzad F, Marashian SM, Younespour S. The healing effect of nano-silver dressings in pemphigus vulgaris. Wounds. 2015;2(2).
   Google Scholar